UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Mundipharma to commercialize Samsung Bioepis’ biosimilar in Hong Kong, Taiwan
Mundipharma said that it has entered into a partnership with Samsung Bioepi...
by Lee Han-soo
|
2020-01-13 16:23
라인
BioMarin seeks license for gene therapy to treat hemophilia
The world might be one step closer to the eradication of hemophilia.BioMari...
by Kim Yun-mi
|
2020-01-06 16:44
라인
[New Year Special] Biotech rookies may shake up market cap rankings
Korean biotech companies, which drove up the buying spree on the Kosdaq mar...
by Jeong Sae-im
|
2020-01-02 14:31
라인
Humedix wins patent on new anti-aging material
Humedix said it has won a local patent on a new substance called “nicotinam...
by Jeong Sae-im
|
2019-12-26 14:31
라인
Vaxcell-Bio Therapeutics passes tech review for Kosdaq debut
Vaxcell-Bio Therapeutics, an immunotherapy developer, said it has passed th...
by Jeong Sae-im
|
2019-12-23 15:42
라인
Samsung Bioepis’ Ontruzant 1st biosimilar to win WHO's PQ certification
Samsung Bioepis announced that Ontruzant, a trastuzumab biosimilar (Origina...
by Lee Han-soo
|
2019-12-20 16:29
라인
Kolon appeals Invossa’s safety in pleading at court
Kolon Life Science is working flat out to prove the safety of Invossa-K, th...
by Jeong Sae-im
|
2019-12-20 14:57
라인
4 firms to offer up to 56 direct-to-consumer genetic testing services
The government said it has allowed four companies, including Theragen Etex ...
by Jeong Sae-im
|
2019-12-19 16:40
라인
Psomagen-Macrogen consortium acquires uBiome's patents, data
Psomagen and Macrogen said that they have acquired uBiome's 246 microbi...
by Lee Han-soo
|
2019-12-18 16:56
라인
Venture capital investment in biomedical sector to hit record this year
Despite disappointing clinical trial failures by major biotech firms, ventu...
by Jeong Sae-im
|
2019-12-17 14:20
라인
Celltrion secures 11 generic drugs to advance to US market
Celltrion said it is speeding up efforts to enter into the U.S. market afte...
by Lee Han-soo
|
2019-12-16 17:02
라인
Helixmith to clarify why gene therapy study had data error
Helixmith said it would announce next month the cause of the data error in ...
by Jeong Sae-im
|
2019-12-13 15:13
라인
Yuhan to start phase-3 trial on lung cancer drug Lazertinib
Yuhan Corp. said it would start a phase-3 global study to evaluate the effi...
by Jeong Sae-im
|
2019-12-12 15:04
라인
Aprogen, 1st Korean biotech firm to win unicorn status
Aprogen has joined the list of unicorn companies, as the first Korean biote...
by Jeong Sae-im
|
2019-12-11 13:10
라인
Samsung Bioepis to start P3 trial for Ontruzant in China
Samsung Bioepis said that China’s National Medical Products Administration ...
by Lee Han-soo
|
2019-12-10 14:16
라인
Samsung execs get jail term for destroying evidence
A Seoul court gave jail terms to Samsung executives for destroying evidence...
by Jeong Sae-im
|
2019-12-10 11:43
라인
Celltrion unveils long-term P3 trial results for Truxima in US
Celltrion said that it has presented the long-term follow-up results of its...
by Lee Han-soo
|
2019-12-09 10:36
라인
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports
Celltrion Healthcare said that it has become the first local biopharmaceuti...
by Lee Han-soo
|
2019-12-05 15:04
라인
Alteogen inks licensing-out deal for SC injection formulation technology
Alteogen, a biotech firm, said it has successfully concluded a deal to make...
by Jeong Sae-im
|
2019-12-02 15:25
라인
Kolon Life Science’s research head arrested for false Invossa data
A Seoul court issued an arrest warrant for an executive at Kolon Life Scien...
by Jeong Sae-im
|
2019-11-28 11:18
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top